Retrospective evaluation of prospective data from severely ill patients in need of ICU treatments with COVID-19 regarding to superinfections

• Conditions: U07.1; COVID-19, virus identified

• Registration Number: DRKS00024687
• Lead Sponsor: Helios Klinikum Berlin Buch

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-17
• Study Completion: 2021-07-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 1951

Inclusion Criteria

ICU period caused by COVID-19

Exclusion Criteria

ICU period is before the positive SARS-CoV-2 test. Case is ongoing at the end of the trial.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Detection of superinfections in severely ill patients with COVID-19.

Secondary Outcome Measures

Name	Time	Method
Impact of bloodstream catheters and ventilation on Superinfections; use of antibacterial therapies.